SARS-CoV Spike anticorps (N-Term)

N° du produit ABIN6990115

Détail du produit anti-SARS-CoV Spike anticorps

Antigène: SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))

Épitope: N-Term

Reactivité: SARS Coronavirus (SARS-CoV)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SARS-CoV Spike est non-conjugé

Application: ELISA

Purification: SARS-CoV Spike Antibody is affinity chromatography purified via peptide column.

Immunogène: Anti-SARS-CoV Spike antibody was raised against a peptide corresponding to 14 amino acids near the amino of SARS-CoV Spike glycoprotein. The immunogen is located within the first 50 amino acids of SARS-CoV Spike.

Isotype: IgG

Information d'application

Indications d'application: SARS-CoV Spike antibody can be used for the detection of SARS-CoV Spike protein in ELISA. It will detect 5 ng of free peptide at 1 μ,g/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: SARS-CoV Spike Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: SARS-CoV Spike antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur SARS-CoV Spike

Antigène: SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))

Autre désignation: SARS-CoV Spike (SARS-CoV S Produits)

Classe de substances: Viral Protein

Sujet: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

ID gène: 1489668

UniProt: P59594